StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Fidelity 22 and Penson 5

<< Previous

Bullboard Posts

Next >>

Comment by 4real4everon Sep 09, 2021 1:37pm

143 Views

Post# 33834271

RE:Fidelity 22 and Penson 5

Photoman77 wrote: Fidelity 22 and Penson 5 seem to be buying together today. Not sure if this has been a trend but it seems to be the same buyer buying through two accounts at the same time.

Stop talking about Fidelity they buy nothing. The stock has no volume for months. Remember the Clarus buying, before them was Echelon and the share still at $0,05

Now everyone wait for the supposed big February quarter one year after the Aristotle launch

Um Hello GIFs - Get the best GIF on GIPHY